Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

被引:275
|
作者
Fricker, Gert [1 ,7 ]
Kromp, Torsten [6 ]
Wendel, Armin [6 ,7 ]
Blume, Alfred [5 ,7 ]
Zirkel, Juergen [4 ,7 ]
Rebmann, Herbert [4 ,7 ]
Setzer, Constanze [4 ,7 ]
Quinkert, Ralf-Olaf [4 ,7 ]
Martin, Frank [3 ,7 ]
Mueller-Goymann, Christel [2 ,7 ]
机构
[1] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[2] Tech Univ, Inst Pharmaceut Technol, D-38106 Braunschweig, Germany
[3] iMEDD Inc, Columbus, OH USA
[4] Lipoid GmbH, D-67065 Ludwigshafen, Germany
[5] Martin Luther Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Germany
[6] Phospholipid GmbH, D-50829 Cologne, Germany
[7] Phospholipid Res Ctr, D-69120 Heidelberg, Germany
关键词
emulsion; liposome; phospholipid; self-emulsifying drug delivery systems; solid lipid nanoparticles; INTESTINAL LYMPHATIC TRANSPORT; CYCLOSPORINE-A; IN-VIVO; PROLIPOSOMAL SYSTEMS; NANOPARTICLES SLN; BODY DISTRIBUTION; COATED LIPOSOMES; CARRIER SYSTEM; NEW-MODEL; ABSORPTION;
D O I
10.1007/s11095-010-0130-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Phospholipids become increasingly important as formulation excipients and as active ingredients per se. The present article summarizes particular features of commonly used phospholipids and their application spectrum within oral drug formulation and elucidates current strategies to improve bioavailability and disposition of orally administered drugs. Advantages of phospholipids formulations not only comprise enhanced bioavailability of drugs with low aqueous solubility or low membrane penetration potential, but also improvement or alteration of uptake and release of drugs, protection of sensitive active agents from degradation in the gastrointestinal tract, reduction of gastrointestinal side effects of non-steroidal anti-inflammatory drugs and even masking of bitter taste of orally applied drugs. Technological strategies to achieve these effects are highly diverse and offer various possibilities of liquid, semi-liquid and solid lipid-based formulations for drug delivery optimization.
引用
收藏
页码:1469 / 1486
页数:18
相关论文
共 50 条
  • [1] Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
    Gert Fricker
    Torsten Kromp
    Armin Wendel
    Alfred Blume
    Jürgen Zirkel
    Herbert Rebmann
    Constanze Setzer
    Ralf-Olaf Quinkert
    Frank Martin
    Christel Müller-Goymann
    [J]. Pharmaceutical Research, 2010, 27 : 1469 - 1486
  • [2] Lipid-Based Formulations for Oral Drug Delivery: Effects on Drug Absorption and Metabolism
    Zhu, Quanlei
    Li, Xiuying
    Xia, Dengning
    Yu, Hongzhen
    Chen, Dan
    Fan, Weiwei
    Gan, Yong
    [J]. CURRENT DRUG METABOLISM, 2015, 16 (03) : 200 - 210
  • [3] Controlling the drug delivery attributes of lipid-based drug formulations
    Bally, MB
    Lim, H
    Cullis, PR
    Mayer, LD
    [J]. JOURNAL OF LIPOSOME RESEARCH, 1998, 8 (03) : 299 - 335
  • [4] The effect of drug ionization on lipid-based formulations for the oral delivery of anti-psychotics
    Meola, Tahlia R.
    Paxton, Kara
    Joyce, Paul
    Schultz, Hayley B.
    Prestidge, Clive A.
    [J]. ADMET AND DMPK, 2020, 8 (04): : 437 - 451
  • [5] Oral lipid-based formulations
    Hauss, David J.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 667 - 676
  • [6] Palm Oil in Lipid-Based Formulations and Drug Delivery Systems
    Goon, Danial Efendy
    Kadir, Siti Hamimah Sheikh Abdul
    Ab Latip, Normala
    Ab Rahim, Sharaniza
    Mazlan, Musalmah
    [J]. BIOMOLECULES, 2019, 9 (02)
  • [7] Recent developments in oral lipid-based drug delivery
    Thomas, N.
    Rades, T.
    Mullertz, A.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2013, 23 (04) : 375 - 382
  • [8] Oral lipid-based drug delivery systems an overview
    Kalepu, Sandeep
    Manthina, Mohanvarma
    Padavala, Veerabhadhraswamy
    [J]. ACTA PHARMACEUTICA SINICA B, 2013, 3 (06) : 361 - 372
  • [9] Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide
    Peng Li
    Leigh Ford
    Shadabul Haque
    Mitchell P. McInerney
    Hywel D. Williams
    Peter J. Scammells
    Philip E. Thompson
    Vincent Jannin
    Christopher J. H. Porter
    Hassan Benameur
    Colin W. Pouton
    [J]. Pharmaceutical Research, 2021, 38 : 1125 - 1137
  • [10] Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
    Christopher J. H. Porter
    Natalie L. Trevaskis
    William N. Charman
    [J]. Nature Reviews Drug Discovery, 2007, 6 : 231 - 248